Benzinga on MSN1mon
Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
In the late 1990s, the FDA expressed concerns regarding the diminishing potency of Merck & Co., Inc.’s (NYSE:MRK) mumps ...
Benzinga.com17d
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
In June this year, the FDA approved Merck’s Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) to protect against 21 strains of bacteria to prevent a severe form of pneumococcal disease.
pharmaphorum1mon
Drugs and vaccines may not swiftly end pandemic, says Merck & Co's CEO
Merck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly end the pandemic. Speaking to CNBC, Frazier said that the ...
Merck Beats Q3 Estimates, But Lowers Annual Forecast As Gardasil Vaccine Hit By Low China Demand
Merck reports Q3 sales of $16.7 billion, up 4% year-over-year, with Keytruda revenue rising 17%. EPS beats estimates; 2024 guidance updated on global demand shifts.
Veterinary Vaccines Market is expected to generate a revenue of USD 27.5 Billion By 2030, Globally, at 9.5% CAGR: Verified Market Research
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Veterinary ...
Yahoo Finance1mon
Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
The vaccine is expected to be available at veterinary clinics and hospitals nationwide this fall. NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health’s ...